B
Berta Segura-Collar
Researcher at Carlos III Health Institute
Publications - 20
Citations - 222
Berta Segura-Collar is an academic researcher from Carlos III Health Institute. The author has contributed to research in topics: Glioma & Medicine. The author has an hindex of 6, co-authored 13 publications receiving 100 citations.
Papers
More filters
Journal ArticleDOI
The IDH-TAU-EGFR triad defines the neovascular landscape of diffuse gliomas.
Ricardo Gargini,Ricardo Gargini,Berta Segura-Collar,Beatriz Herranz,Beatriz Herranz,Vega García-Escudero,Andrés Romero-Bravo,Felipe J Nunez,Daniel García-Pérez,Jacqueline Gutiérrez-Guamán,Angel Ayuso-Sacido,Angel Ayuso-Sacido,Joan Seoane,Angel Perez-Nuñez,Juan M. Sepúlveda-Sánchez,Aurelio Hernández-Laín,Maria G. Castro,Ramón García-Escudero,Jesús Avila,Pilar Sánchez-Gómez +19 more
TL;DR: The transcription of microtubule-associated protein TAU (MAPT), a gene that has been classically associated with neurodegenerative diseases, is epigenetically controlled by the balance between wt and mut IDH1/2 in mouse and human gliomas.
Journal ArticleDOI
Cellular Plasticity and Tumor Microenvironment in Gliomas: The Struggle to Hit a Moving Target.
TL;DR: The new genetic and epigenetic classification of gliomas and the description of the different transcriptional subtypes are revised and the interaction of the plastic tumor cells with their vasculature-rich microenvironment and with their distinct immune system is focused on.
Journal ArticleDOI
Novel Functions of the Neurodegenerative-Related Gene Tau in Cancer.
TL;DR: The main knowledge about Tau function and expression in tumors is reviewed, with a special focus on brain cancer, and its function in cancer has not yet been addressed.
Journal ArticleDOI
Oncogenic dependence of glioma cells on kish/TMEM167A regulation of vesicular trafficking
Marta Portela,Berta Segura-Collar,Irene Argudo,Almudena Saiz,Ricardo Gargini,Pilar Sánchez-Gómez,Sergio Casas-Tintó +6 more
TL;DR: It is suggested that glioma growth depends on modifications of the vesicle transport system, reliant on kish/TMEM167A, which could be a key for future therapeutic strategies targeting EGFR‐dependent gliomas.
Journal ArticleDOI
Tumor-derived pericytes driven by EGFR mutations govern the vascular and immune microenvironment of gliomas
Berta Segura-Collar,María Garranzo-Asensio,Beatriz Herranz,Beatriz Herranz,Esther Hernández-SanMiguel,Teresa Cejalvo,Bárbara S. Casas,Ander Matheu,Ander Matheu,Angel Perez-Nuñez,Juan M. Sepúlveda-Sánchez,Aurelio Hernández-Laín,Verónica Palma,Ricardo Gargini,Pilar Sánchez-Gómez +14 more
TL;DR: In this paper, the authors identify the EGFR-related mechanisms that govern the capacity of glioma cells to transdifferentiate into pericytes, regulating the vascular and immune phenotypes of the tumors.